-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, NLdGxCzImF4oMZAKA6LOj0HM8/PrMJQx/8VSCGwwD+baIE6KkdmNxg8qpc0L25yr HuK8scBwBjwIRBTtg6VJfA== 0001264124-04-000034.txt : 20040227 0001264124-04-000034.hdr.sgml : 20040227 20040227190046 ACCESSION NUMBER: 0001264124-04-000034 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20040227 FILED AS OF DATE: 20040227 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMYLIN PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000881464 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330266089 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9360 TOWNE CENTRE DR STREET 2: SUITE 110 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 6195522200 MAIL ADDRESS: STREET 1: 9360 TOWNE CENTRE DR STREET 2: SUITE 110 CITY: SAN DIEGO STATE: CA ZIP: 92121 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BRADBURY DANIEL CENTRAL INDEX KEY: 0001236397 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19700 FILM NUMBER: 04637125 BUSINESS ADDRESS: STREET 1: AMYLIN PHARMACEUTICALS INC STREET 2: 9360 TOWNE CENTRE DR CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8585522200 MAIL ADDRESS: STREET 1: AMYLIN PHARMACEUTICALS INC STREET 2: 9360 TOWNE CENTRE DR CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 edgardoc.xml PRIMARY DOCUMENT X0201 4 2004-02-27 0 0000881464 AMYLIN PHARMACEUTICALS INC AMLN 0001236397 BRADBURY DANIEL 9360 TOWNE CENTRE DR SAN DIEGO CA 92121 0 1 0 0 Chief Operating Officer Common Stock 2004-02-27 4 M 0 5907 2.719 A 13392 I by Trust Common Stock 2004-02-27 4 F 0 701 22.91 D 12691 I by Trust Common Stock 16464 D Incentive Stock Option (right to buy) 2.719 2004-02-27 4 M 0 5907 0 D 2004-02-27 2008-04-01 Common Stock 5907 0 I by Trust The direct orwnership of the reporting person includes shares of AMLN common stock acquired pursuant to the Company's match under the AMLN 401(k) plan. Daniel Bradbury 2004-02-27 -----END PRIVACY-ENHANCED MESSAGE-----